News

Activist hedge fund Parvus builds stake in Novo Nordisk, FT reports
Activist hedge fund Parvus Asset Management is building a stake in Novo Nordisk , after the company lost its first mover ...
Zacks Investment Research on MSN3d
Is Novo Nordisk's Next Generation Obesity Pipeline a Game Changer?
Novo Nordisk NVO has seen strong momentum in recent years, driven by the commercial success of its blockbuster semaglutide ...
$2B Novo Nordisk deal shakes up pharma market
Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...
Fresh out of high school, NC workers see $50,000-plus salaries at pharma giants
Wolfspeed bankruptcy watch, North Carolina lands more data centers, Duke University’s funding crunch, and an AI companion ...
Novo Nordisk Stock: Is It Still a Smart Buy?
I've been a Novo Nordisk bull for quite some time now, and I wouldn't be as spooked by the situation. Here's why. Novo Nordisk got a two-year-plus head start in the white-hot obesity drugs market, ...
STAT4d
A cautious culture cost Novo Nordisk its lead in the obesity drug race, former employees say
Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...
STAT4d
An AI experiment at the FDA & Novo trailing in the obesity drug race
This week on "The Readout LOUD" podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug ...
360Dx4d
Randox Laboratories Gains FDA De Novo Clearance for Hemophilia CDx
The Randox ConcizuTrace ELISA is used to determine the concentration in blood of Novo Nordisk's Alhemo (concizumab-mtci) to aid dose adjustments.